NSEAnalysts/Institutional Investor Meet/Con. Call Updates23 Jun 2026 · 23 Jun 2026, 03:51 pm

Analysts/Institutional Investor Meet/Con. Call Updates

Global Health Limited · MEDANTA

✦ AI Summary

Global Health Limited has scheduled virtual one-on-one meetings with institutional investors, including IKIGAI Asset Manager Holdings Private Limited on June 26, 2026, and Enam Asset Management Company Private Limited on June 30, 2026. These meetings are pursuant to SEBI Listing Regulations. The company explicitly stated that no Unpublished Price Sensitive Information is intended to be shared during these interactions.

Analysis Scores

Earnings Impact5/10
Growth Catalyst5/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk5/10
Liquidity Impact5/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Global Health Limited has informed the Exchange about Schedule of meet

Attachments (1)

📄

MEDANTA21_23062026154915_GHLANALYSTSMEETJUNE232026Signed.pdf

pdf

Download →
View document text
June 23, 2026 Ref:- GHL/2026-27/EXCH/26 The General Manager The Manager Dept. of Corporate Services Listing Department BSE Limited, National Stock Exchange of India Limited P J Towers, Dalal Street, Exchange Plaza, C-1, Block G, Mumbai - 400 001 Bandra Kurla Complex, Bandra (E), Mumbai - 400 051 Scrip Code: 543654 Symbol: MEDANTA Sub: Intimation for Schedule of Analysts/Institutionals Investor Meeting Dear Sir(s), Pursuant to Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Company’s Management will meet Investors/Analysts in Meetings organised as per the below schedule: Name Date of Meeting Type of Meeting Mode of Meeting IKIGAI Asset Manager June 26, 2026 one to one Virtual Holdings Private Limited Enam Asset Management June 30, 2026 one to one Virtual Company Private Limited Please note that, no Unpublished Price Sensitive Information is proposed to be shared, thereat. Note: Please note that the above meeting is subject to change in case of any unforeseen circumstances, on the part of Analysts/Investors/Company. Kindly take the above on record. For Global Health Limited Rahul Ranjan Company Secretary & Compliance Officer M. No. A17035 Regd. Office: E-18, Defence Colony, New Delhi 110024, Ph No.011- 44114411 www.medanta.org, info@medanta.org, CIN: L85110DL2004PLC128319